Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 12;17(2):24.
doi: 10.3390/idr17020024.

Phage Therapy for Mycobacteria: Overcoming Challenges, Unleashing Potential

Affiliations
Editorial

Phage Therapy for Mycobacteria: Overcoming Challenges, Unleashing Potential

Christoffel Johannes Opperman et al. Infect Dis Rep. .

Abstract

Bacteriophage (phage) therapy is emerging as a promising alternative to traditional antibiotics for treating drug-resistant mycobacterial infections, including Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) [...].

PubMed Disclaimer

Conflict of interest statement

The authors have no competing conflict of interest to declare concerning the material discussed in the article.

References

    1. Opperman C.J., Wojno J., Goosen W., Warren R. Phages for the treatment of Mycobacterium species. Prog. Mol. Biol. Transl. Sci. 2023;201:41–92. doi: 10.1016/bs.pmbts.2023.03.016. - DOI - PubMed
    1. Opperman C.J., Wojno J.M., Brink A.J. Treating bacterial infections with bacteriophages in the 21st century. S. Afr. J. Infect. Dis. 2022;37:346. doi: 10.4102/sajid.v37i1.346. - DOI - PMC - PubMed
    1. Zeynali Kelishomi F., Khanjani S., Fardsanei F., Saghi Sarabi H., Nikkhahi F., Dehghani B. Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: A review. BMC Infect. Dis. 2022;22:957. doi: 10.1186/s12879-022-07944-9. - DOI - PMC - PubMed
    1. Jia H.J., Jia P.P., Yin S., Bu L.K., Yang G., Pei D. Engineering bacteriophages for enhanced host range and efficacy: Insights from bacteriophage-bacteria interactions. Front. Microbiol. 2023;14:1172635. doi: 10.3389/fmicb.2023.1172635. - DOI - PMC - PubMed
    1. Borin J.M., Lee J.J., Gerbino K.R., Meyer J.R. Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages. Evol. Appl. 2022;16:152–162. doi: 10.1111/eva.13518. - DOI - PMC - PubMed

Publication types

LinkOut - more resources